Fr. Donohue, 2020 Taoiseach Award Recipient (2/28/20)

THE INTERVIEW: Villanova’s Peter Donohue on leadership during the pandemic
Philadelphia Business Journal

Despite having about 5,000 students living on campus this semester, Rev. Peter Donohue says Villanova University is disquietingly … quiet.

The coronavirus pandemic has prevented student gatherings of any kind at the Catholic college in Radnor Township, Pennsylvania, so there’s “really nothing going on but academics,” said Donohue, now in his 14th year at the school’s helm.

The downtime has enabled the Augustinian priest to reflect on the role of a college president during a global pandemic — and on leadership in general — while simultaneously encouraging a community of young adults to sacrifice their individual needs to ensure the safety and wellbeing of the entire group (i.e. adhere to Covid-19 protocols). So far, his self-described stint as Villanova’s chief cheerleader has paid off with minimal confirmed coronavirus cases on campus and an otherwise uneventful start to the 2020-21 academic year.

Donohue recently spoke with The Business Journals’ Hilary Burns about how his job has changed since Covid-19 struck, and the effects the pandemic is having on college pricing and on-campus learning. Below is an edited transcript of their conversation.

Read More

Emergent BioSolutions announced that its COVID-19 Human Immune Globulin (COVID-HIG) product candidate will be evaluated in an NIH-sponsored phase 3 clinical trial of hyperimmune intravenous immunoglobulins to treat COVID-19

GAITHERSBURG, Md., Oct. 08, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of the Phase 3 clinical trial that will evaluate plasma-derived therapy COVID-HIG as a potential treatment for hospitalized patients with coronavirus disease (COVID-19). The INSIGHT-013 clinical study called “Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC),” is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The study will evaluate the safety, tolerability, and efficacy of hyperimmune globulin products derived from plasma of individuals who have recovered from COVID-19 and have developed neutralizing antibodies to SARS-CoV-2, the virus that causes COVID-19. The randomized controlled clinical trial assigns participants to receive infusions of either a placebo or one of four hyperimmune globulin products, which includes Emergent’s COVID-HIG, with a background therapy of remdesivir in all groups.

Read More

Aramark partners with Starship Technologies to launch delivery robots on college campus
Philadelphia Business Journal

The future of delivery services is scooting around Arizona State University’s Tempe campus after a partnership between Philadelphia-based food provider Aramark and California-based Starship Technologies brought in a fleet of sidewalk-traveling autonomous delivery robots.

Anyone on the ASU campus can download the Starship app on iOS or Android and have Aramark meals delivered.

Options for food delivery, which began in late August, include Starbucks, Burger King, QDOBA, Pei Wei, Subway, Jamba Juice, Chick-in and Einstein Bros. Bagels. POD Market items are also deliverable — from frozen food to health supplies.

Click HERE to read more.

We are thrilled to welcome Mr. Patrick J. Ward to our Board of Directors.

Patrick Ward joined WSFS Bank in August 2016 as Executive Vice President, Pennsylvania Market President. Mr. Ward served on the Board of Directors of WSFS Financial Corporation until April 23, 2020. Previously, he was Chairman of the Board and Chief Executive Officer of Penn Liberty Bank from 2004 to 2016.

He served as Executive Vice President of Citizens Bank of Pennsylvania from January 2003 until January 2004, he oversaw specialized industries, including the Government Banking, Professionals Banking and Not-For-Profit Businesses in the Mid-Atlantic region.  Additionally, he was Chairman and President of Citizens Bank in Delaware and a member of the Citizens Financial Group Executive Policy Committee.

Prior to Citizens Bank, he served as President and Chief Executive Officer for Commonwealth Bank until its acquisition by Citizens Bank in January 2003. Under his leadership, Commonwealth Bank grew to $1.8 billion in assets including 61 branches throughout eastern Pennsylvania.

Preceding his time with Commonwealth Bank, Mr. Ward held a variety of positions at Mellon Bank in Pittsburgh, Pennsylvania, including Vice President and Controller of Mellon Bank’s Wholesale Banking Group and Vice President and Controller of its Retail Banking Group.

Mr. Ward is active in the community, serving on the Board of Directors of the Philadelphia Police Athletic League as Vice Chairman, the Chester County Chamber of Business and Industry, the Foundation for Catholic Education for Southeast PA, the Brian C. Zwaan Legacy Fund, the Philadelphia Police Foundation, and the Chester County Food Bank.  He is on the Board of Trustees for Cabrini College and the St. Patrick’s Church Finance Committee.

He is also currently an Operating Advisor for Falcon Capital Partners, a local investment bank providing sell side and strategic advisory services to middle market companies.

Mr. Ward is a graduate of Carnegie Mellon University with a Bachelor of Science degree in economics and earned an MBA from the University of Notre Dame. He resides in Chester County.